文献速递儿童心血管与肾脏

儿童慢性肾脏病5期病因与并发症分析

[Analysis of etiology and complications in children with stage 5 chronic kidney disease].
PubMed 文献 · Zhonghua Er Ke Za Zhi · 2023-01-01

回顾性分析174例CKD5期患儿,CAKUT最常见(48.3%),贫血最常见(98.2%),并发症发生率随年龄、性别和病因不同,腹膜透析组存活比例高于血液透析组。

要点

  • CAKUT是儿童CKD5期最常见病因,贫血是最常见并发症。
  • 继发性肾小球疾病高血压发生率高于CAKUT和遗传性肾小球病。
  • 腹膜透析组贫血、低钙、高磷纠正及存活比例优于血液透析组。

核心结论

  • CAKUT是儿童CKD5期最常见病因,贫血是最常见并发症。
  • 贫血、高血压、低白蛋白血症、碱性磷酸酶降低与LVMI升高可能是CKD5期患儿预后相关因素。
  • 腹膜透析可能更有利于CKD5期患儿长期存活。

研究设计与样本

  • 病例系列研究,回顾性分析2012年4月至2021年4月重庆医科大学附属儿童医院174例CKD5期住院患儿。
  • 随访至2022年10月,比较不同年龄、性别、病因组并发症,分析LVH影响因素及预后因素。

主要发现

  • CAKUT 84例(48.3%),肾小球疾病83例(47.7%),其中遗传性肾小球病28例(16.1%)。
  • 贫血98.2%(165/168),CKD-MBD 97.7%(170/174),脂代谢紊乱87.5%(63/72),高血压81.4%(127/156),LVH 57.6%(57/99)。
  • 113例随访患儿病死率39.8%(45/113),死亡组血红蛋白低、收缩压和舒张压高、白蛋白低、碱性磷酸酶低、左心室质量指数高(均P<0.05)。
  • 未发现预后相关独立危险因素(均P>0.05)。

关键数值与推荐

  • 原发性肾小球疾病高血压发生率93.8%(30/32)高于CAKUT 73.7%(56/76),χ2=5.59,P<0.05。
  • 继发性肾小球疾病高血压发生率100.0%(20/20)高于CAKUT 73.7%(56/76)和遗传性肾小球病68.2%(15/22),均P<0.05。
  • CAKUT、原发性肾小球疾病及遗传性肾小球病低钙血症发生率82.1%(69/84)、88.2%(30/34)、89.3%(25/28)均高于继发性肾小球疾病47.6%(10/21),χ2=10.21、10.75、10.80,均P=0.001。
  • 女性继发性甲状旁腺功能亢进发生率95.0%(57/60)高于男性80.0%(64/80),χ2=6.58,P=0.010。
  • 6~<12岁患儿LVH发生率73.5%(25/34)高于12~18岁43.1%(22/51),χ2=7.62,P=0.006。

临床怎么用

  • 对CKD5期患儿应常规评估贫血、CKD-MBD、脂代谢紊乱、高血压和LVH。
  • 关注不同病因、年龄和性别患儿的并发症差异,个体化监测。
  • 腹膜透析可能更有利于改善贫血、低钙、高磷及长期存活。

局限性

  • 为单中心回顾性病例系列研究。
  • 部分并发症数据存在缺失(如脂代谢紊乱仅72例、LVH仅99例有数据)。
  • 未发现预后相关独立危险因素,可能受样本量限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the etiology, complications, and prognostic factors of stage 5 chronic kidney disease (CKD5) in children. Methods: A case series study was conducted to retrospectively analyze the general situation, clinical manifestations, laboratory tests, genetic testing, and follow-up data (until October 2022) of 174 children with CKD5 who were diagnosed and hospitalized at the Children's Hospital of Chongqing Medical University from April 2012 to April 2021. The characteristics of complications in the children were compared based on age, gender, and etiology. Based on the presence or absence of left ventricular hypertrophy (LVH), patients were divided into LVH group and non LVH group for analyzing the influencing factors of cardiovascular disease. Patients were also divided into death group and survival group, peritoneal dialysis group and hemodialysis group based on the follow-up data for analyzing the prognostic factors. The chi-square test, independent sample t-test, Fisher exact probability test, Mann-Whitney U test and Kruskal Wallis test were used to analyze data among different groups. Multivariate Logistic regression analysis was used to identify the prognostic factors. Results: A total of 174 children with CKD5 were enrolled in the study (96 boys and 78 girls), aged 11.2 (8.2, 13.0) years. Congenital kidney and urinary tract malformations (CAKUT) were the most common causes of the CKD5 (84 cases, 48.3%), followed by glomerular diseases (83 cases, 47.7%), and among which 28 cases (16.1%) were hereditary glomerular diseases. The common complications of CKD5 included anemia (98.2%, 165/168), mineral and bone disorder in chronic kidney disease (CKD-MBD) (97.7%, 170/174), lipid metabolism disorders (87.5%, 63/72), hypertension (81.4%, 127/156) and LVH (57.6%,57/99). The incidences of hypertension in primary glomerular disease were higher than that in CAKUT(93.8%(30/32) vs.73.7%(56/76),χ2=5.59,P<0.05). The incidences of hypertension in secondary glomerular disease were higher than that in CAKUT and that in hereditary kidney disease (100.0%(20/20) vs. 73.7%(56/76), 68.2%(15/22), both P<0.05). The incidence of hypocalcemia in CAKUT, primary glomerular disease, and hereditary kidney disease was higher than that in secondary glomerular disease (82.1%(69/84), 88.2%(30/34), 89.3%(25/28) vs. 47.6%(10/21), χ2=10.21, 10.75, 10.80, all P=0.001); the incidence of secondary hyperparathyroidism in women was higher than that in men (80.0%(64/80) vs. 95.0%(57/60), χ2=6.58, P=0.010). The incidence of LVH in children aged 6-<12 was higher than that in children aged 12-18 (73.5%(25/34) vs. 43.1%(22/51), χ2=7.62, P=0.006). Among 113 follow-up children, the mortality rate was 39.8% (45/113). Compared to the survival group, the children in the death group had lower hemoglobin, higher blood pressure, lower albumin, lower alkaline phosphatase and higher left ventricular mass index ((67±19) vs. (75±20) g/L, 142 (126, 154) vs. 128(113, 145) mmHg(1 mmHg=0.133 kPa), (91±21) vs. (82±22) mmHg, 32 (26, 41) vs. 40 (31, 43) g/L, 151 (82, 214) vs. 215 (129, 37) U/L, 48 (38, 66) vs. 38(32, 50) g/m2.7,t=2.03, Z=2.89, t=2.70, Z=2.49, 2.79, 2.29,all P<0.05), but no independent risk factors were identified (all P>0.05). The peritoneal dialysis group had better alleviation for anemia, low calcium, and high phosphorus than the hemodialysis group ((87±22) vs. (72±16) g/L, (1.9±0.5) vs. (1.7±0.4) mmol/L, (2.2±0.7) vs. (2.8±0.9) mmol/L, t=2.92, 2.29, 2.82, all P<0.05), and the survival rate of the peritoneal dialysis group was significantly higher than that of the hemodialysis group (77.8% (28/36) vs. 48.4% (30/62), χ2=8.14, P=0.004). Conclusions: CAKUT is the most common etiology in children with CKD 5, and anemia is the most common complication. The incidence of complications in children with CKD 5 varies with age, gender and etiology. Anemia, hypertension, hypoalbuminemia, reduced alkaline phosphatase and elevated LVMI may be the prognostic factors in children with CKD5. Peritoneal dialysis may be more beneficial for improving the long-term survival rate. 目的: 了解儿童慢性肾脏病(CKD)5期的病因、并发症及影响疾病预后的因素。 方法: 病例系列研究,回顾性分析2012年4月至2021年4月于重庆医科大学附属儿童医院确诊CKD 5期并住院治疗的174例患儿的一般情况、临床表现、实验室检查、基因检测及随访情况(截至2022年10月)等临床资料,根据年龄、性别和病因分组比较患儿并发症的特点;根据有无左心室肥厚(LVH)分为LVH组和非LVH组,分析发生心血管疾病的影响因素;根据随访时情况分为死亡组和存活组、腹膜透析组和血液透析组,分析影响预后的相关因素。组间比较采用χ2检验、独立样本t检验、Fisher确切概率法、Mann-Whitney U检验及Kruskal-Wallis检验,采用二元Logistic回归分析与疾病预后相关的因素。 结果: 174例CKD 5期患儿中男96例、女78例,初诊年龄11.2(8.2,13.0)岁。主要病因为先天性肾脏和尿路畸形(CAKUT)(84例,48.3%)及肾小球疾病(83例,47.7%),其中遗传性肾小球病28例(16.1%)。主要并发症依次为贫血(98.2%,165/168),慢性肾脏病合并骨矿物质代谢异常(CKD-MBD)(97.7%,170/174),脂代谢紊乱(87.5%,63/72),高血压(81.4%,127/156),LVH(57.6%,57/99)。原发性肾小球疾病高血压发生率高于CAKUT[93.8%(30/32)比73.7%(56/76),χ2=5.59,P<0.05],继发性肾小球疾病高血压发生率高于CAKUT和遗传性肾小球病[100.0%(20/20)比73.7%(56/76)、68.2%(15/22),均 P<0.05]。CAKUT、原发性肾小球疾病及遗传性肾小球病的低钙血症发生率均高于继发性肾小球疾病[82.1%(69/84)、88.2%(30/34)、89.3%(25/28)比47.6%(10/21),χ2=10.21、10.75、10.80,均P=0.001]。女性继发性甲状旁腺功能亢进发生率高于男性[80.0%(64/80)比95.0%(57/60),χ2=6.58,P=0.010]。6~<12岁患儿LVH发生率高于12~18岁[73.5%(25/34)比43.1%(22/51),χ2=7.62,P=0.006]。113例随访患儿中,病死率为39.8%(45/113),死亡组患儿较存活组血红蛋白低、收缩压高、舒张压高、白蛋白低、碱性磷酸酶低、左心室质量指数高[(67±19)比(75±20)g/L、142(126,154)比128(113,145)mmHg(1 mmHg=0.133 kPa)、(91±21)比(82±22)mmHg、32(26,41)比40(31,43)g/L、151(82,214)比215(129,37)U/L、48(38,66)比38(32,50)g/m2.7,t=2.03,Z=2.89,t=2.70,Z=2.49、2.79、2.29,均P<0.05],未发现预后相关独立危险因素(均P>0.05);腹膜透析组患儿贫血、低钙、高磷纠正均优于血液透析组[(87±22)比(72±16)g/L、(1.9±0.5)比(1.7±0.4)mmol/L、(2.2±0.7)比(2.8±0.9)mmol/L,t=2.92、2.29、2.82,均P<0.05],腹膜透析组患儿存活比例明显高于血液透析组[77.8%(28/36)比48.4%(30/62),χ2=8.14,P=0.004]。 结论: CKD 5期患儿病因以CAKUT多见;贫血是最常见的并发症;不同年龄、性别及病因CKD 5期患儿并发症发生率存在差异;贫血、高血压、低白蛋白血症、碱性磷酸酶降低与LVMI升高可能是CKD 5期患儿的预后相关因素;腹膜透析可能更有利于患儿长期存活。.

来源:Zhonghua Er Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhong C, Chen YL, Yu XX, et al. [Analysis of etiology and complications in children with stage 5 chronic kidney disease]. Zhonghua Er Ke Za Zhi. 2023. PMID: 38018048. doi:10.3760/cma.j.cn112140-20230728-00044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。